Pharma plant begins production in Bahrain

Reuters Images/Ali Jarekji

These are the first pharmaceuticals to be produced in Bahrain

Staff Writer, Gulf Daily News

March 21, 2023

PHOTO

A PHARMACEUTICAL factory in Bahrain has started manufacturing a cough syrup and Omega-3 capsules.

The National Health Regulatory Authority (NHRA) yesterday announced that the Bahrain International Medicine Manufacturing Company Limited (Bahrain Pharma) has started producing Omegarin Soft Gel Capsules (Omega-3) and Ivynise Syrup (Cough Syrup), at the plant located in the Bahrain International Investment Park (BIIP), Hidd.

“These are the first pharmaceuticals to be produced in Bahrain,” said a statement.

“The products will be marketed in Saudi Arabia, Oman, Kuwait, Iraq and Yemen.”

The NHRA granted the company a manufacturing licence in 2020 and certified it as a “Good Manufacturing Practice facility” last year.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.